Expand GLSI Menu
GLSI MENU

GLSI Latest Press Releases

-- April 30, 2026 --

Greenwich LifeSciences Provides Update Regarding Form 10-K Filing Globe Newswire 6:00 AM

-- April 23, 2026 --

Greenwich LifeSciences Announces Acceptance of Abstract at ASCO 2026 Globe Newswire 6:00 AM

-- April 22, 2026 --

Greenwich LifeSciences Announces Receipt of Nasdaq Notice Regarding Late Form 10-K Filing Globe Newswire 5:00 PM

-- April 20, 2026 --

Greenwich LifeSciences Presents FLAMINGO-01 Phase III Trial Open Label Data Published at AACR Meeting 2026 Globe Newswire 6:00 AM

-- April 14, 2026 --

Greenwich LifeSciences Provides Update on Financing Strategy Globe Newswire 6:00 AM

-- April 7, 2026 --

Greenwich LifeSciences Provides Update on Patent Claims Potentially Doubling GP2 Market Potential Globe Newswire 6:00 AM

-- March 19, 2026 --

Greenwich LifeSciences Announces Addition of City of Hope to FLAMINGO-01 Globe Newswire 6:00 AM

-- March 18, 2026 --

Greenwich LifeSciences Provides Update on Upcoming AACR Meeting Globe Newswire 6:00 AM

-- March 17, 2026 --

Greenwich LifeSciences Provides Update Showing Continued Reduction in Recurrence Rate in the Open Label Arm of FLAMINGO-01 Globe Newswire 6:00 AM

-- March 16, 2026 --

Greenwich LifeSciences Announces Use of Commercially Manufactured GP2 in FLAMINGO-01 Globe Newswire 6:00 AM

-- March 3, 2026 --

Greenwich LifeSciences Provides Update on Increased Patient Screen Rate in FLAMINGO-01 Globe Newswire 6:00 AM

-- February 24, 2026 --

Greenwich LifeSciences Announces Acceptance of Two Abstracts at AACR Annual Meeting 2026 Globe Newswire 6:00 AM

-- January 27, 2026 --

Greenwich LifeSciences Provides Update on FLAMINGO-01 Cash Burn Rate and Financing Strategy Globe Newswire 6:00 AM

-- January 22, 2026 --

Greenwich LifeSciences Announces FDA Approves Use of Commercially Manufactured GP2 in FLAMINGO-01 Globe Newswire 6:00 AM

-- December 29, 2025 --

Greenwich LifeSciences Extends Lock-up of Directors and Officers to September 30, 2026 Globe Newswire 6:00 AM

-- December 22, 2025 --

Greenwich LifeSciences Provides Additional Updates on FLAMINGO-01 and Corporate Strategy Globe Newswire 6:00 AM

-- December 15, 2025 --

Greenwich LifeSciences Announces Preliminary Analysis Showing 80% Recurrence Rate Reduction in the Open Label Arm of FLAMINGO-01 Globe Newswire 6:00 AM

-- December 8, 2025 --

Greenwich LifeSciences Announces Completion of Enrollment in the Open Label Arm of FLAMINGO-01 Globe Newswire 6:00 AM

-- December 3, 2025 --

Greenwich LifeSciences Provides Global Update on FLAMINGO-01, Screening Over 1,000 Patients to Date Globe Newswire 6:00 AM
Market Data Delayed 15 Minutes